Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Incyte Corporation    INCY

Delayed Quote. Delayed  - 04/28 10:14:59 pm
72.34 USD   -1.16%
04/28 INCYTE : to Present at Upcoming Investor Conferences
04/15 INCYTE : Investor Event at AACR 2016 to Highlight Innovative and Div..
04/15 INCYTE : Investor Event at AACR 2016 to Highlight Innovative and Div..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on INCYTE CORPORATION
04/28 INCYTE : Investor Event at AACR 2016 to Highlight Innovative and Diversified Res..
04/28 INCYTE : to Present at Upcoming Investor Conferences
04/18 INCYTE : Change in Directors or Principal Officers (form 8-K)
04/15 INCYTE : Investor Event at AACR 2016 to Highlight Innovative and Diversified Res..
04/15 INCYTE : Investor Event at AACR 2016 to Highlight Innovative and Diversified Res..
04/14 INCYTE : to Report First Quarter Financial Results
04/06 INCYTE : Entry into a Material Definitive Agreement (form 8-K)
04/06 Biotech Stocks Rally, Extending Recent Upward Trend
04/06 INCYTE : Acquires Rights from Lilly to Develop and Commercialize Ruxolitinib (Ja..
03/31 NASDAQ 100 MOVERS : Endp, incy
03/31 INCYTE : Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results i..
03/29 Immunovaccine Announces 2015 Year-End Results
03/24 INCYTE : Immuno-oncology and Targeted Therapy Portfolio to be Featured at the AA..
03/24 NASDAQ 100 MOVERS : Pypl, incy
03/16 INCYTE : Immuno-oncology and Targeted Therapy Portfolio to be Featured at the AA..
03/09 NASDAQ 100 MOVERS : Regn, wdc
02/29 INCYTE : Joins Patient Organizations Worldwide in Recognition of Rare Disease Da..
02/29 INCYTE : Other Events (form 8-K)
02/29 INCYTE : Joins Patient Organizations Worldwide in Recognition of Rare Disease Da..
02/16 INCYTE : to Present at Upcoming Investor Conferences
02/11 INCYTE : Results of Operations and Financial Condition, Financial Statements and..
02/11 INCYTE : Nasdaq 100 Movers: INCY, TRIP
02/11DJU.S. HOT STOCKS : Hot Stocks to Watch
02/11DJIncyte Reports Profit But Scraps Trials Involving Cancer Drug
02/11 INCYTE : discontinues JANUS 1 study of ruxolitinib plus capecitabine
02/11 INCYTE : tops Street 4Q forecasts
02/11 INCYTE : Reports 2015 Fourth-Quarter and Year-End Financial Results, Provides 20..
02/11 INCYTE : Announces Decision to Discontinue JANUS Studies of Ruxolitinib plus Cap..
02/04 INCYTE : Announces Decision to Stop Phase 2 Sub-study of Ruxolitinib Plus Regora..
01/31 INCYTE : halts study of Incyte's Jakafi as part of colorectal cancer treatment o..
01/28 INCYTE : Nasdaq 100 Movers: EBAY, FB
01/28DJU.S. HOT STOCKS : Hot Stocks to Watch
01/28 INCYTE CORPORATION : Technical Roundup on Biotechnology Equities -- Incyte, Juno..
01/27 AGENUS : Announces Clearance of Investigational New Drug Applications by the FDA..
01/27 ELI LILLY : Lilly and Incyte Announce Submission of New Drug Application to FDA ..
01/27 INCYTE : Announces Decision to Stop Phase 2 Sub-study of Ruxolitinib Plus Regora..
01/26 INCYTE : Change in Directors or Principal Officers (form 8-K)
01/26 NASDAQ 100 MOVERS : Incy, sbac
01/25 NASDAQ 100 MOVERS : Sndk, mat
01/22 NASDAQ 100 MOVERS : Sbux, sbac
01/21 INCYTE : and AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
01/21 INCYTE : "Treatment of B-Cell Malignancies by a Combination Jak and Pi3k Inhibit..
01/21 INCYTE : to Report Fourth Quarter/Year-End Financial Results
01/19DJELI LILLY : Seeks Approval for Rheumatoid-Arthritis Drug
01/19DJELI LILLY : Seeks FDA Approval for Rheumatoid-Arthritis Drug
01/19 INCYTE : Other Events (form 8-K)
01/12 ASTRAZENECA : and Incyte announce new lung cancer clinical trial collaboration
01/12 INCYTE : Enters into Agreement with AstraZeneca
01/11 ASTRAZENECA : Announces Collaborations With Incyte, Moderna In Cancer
01/11 INCYTE : Presents Significant Progress in its Development Portfolio
01/11 INCYTE : Incyte Holdings Assigned Patent
01/11 ASTRAZENECA : Incyte, AstraZeneca lung cancer drug studies announced
2015 INCYTE : Incyte Holdings Assigned Patent
2015 NASDAQ 100 MOVERS : Bidu, ilmn
2015 INCYTE : to Present at the 34th Annual J. P. Morgan Healthcare Conference
2015 ADURO BIOTECH : Receives Milestone Payment From Janssen for Acceptance of Invest..
2015 INCYTE : to Present at the 34th Annual J. P. Morgan Healthcare Conference
2015 INCYTE : Incyte Assigned Patent
2015 INCYTE : Jakafi® ruxolitinib to be Featured in over 60 Abstracts at ASH Annual M..
2015 INCYTE : U.S. Patents Awarded to Inventors in Delaware (Dec. 7)
2015 INCYTE : Incyte Assigned Patent
2015 INCYTE : Two Phase 3 Studies Reinforce Sustained Benefits of Treatment with Jaka..
2015 INCYTE : Phase 3 RESPONSE-2 Study of Jakafi® (ruxolitinib) Meets Primary Endpoin..
2015 INCYTE : Trials continue to point to Incyte drug's effectiveness in fighting som..
2015 INCYTE : CURE® Magazine and Incyte Honor Seven Individuals and One Organization ..
2015 INCYTE : U.S. Patents Awarded to Inventors in Delaware (Nov. 30)
2015 INCYTE : Incyte Assigned Patent
2015 INCYTE : Jakafi® (ruxolitinib) to be Featured in over 60 Abstracts at ASH Annual..
2015 INCYTE : Incyte Assigned Patent
2015 NASDAQ 100 MOVERS : Bmrn, jd
2015 INCYTE : Immunovaccine Announces Financial Results for Quarter Ended September 3..
2015 WYNN RESORTS : Nasdaq 100 Movers: WYNN, INCY
2015 INCYTE : Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in I..
2015 INCYTE : Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrate..
2015 ELI LILLY : Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Dat..
1  2  3  4  5Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials